MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,160 | +146.6% | 49,578 | +104.5% | 0.02% | +257.1% |
Q2 2023 | $876 | +440.7% | 24,243 | +458.0% | 0.01% | +250.0% |
Q1 2023 | $162 | -100.0% | 4,345 | -90.4% | 0.00% | -94.9% |
Q3 2022 | $3,163,000 | +342.4% | 45,289 | +325.2% | 0.04% | +387.5% |
Q2 2022 | $715,000 | -84.8% | 10,652 | -81.4% | 0.01% | -77.1% |
Q1 2022 | $4,712,000 | +197.5% | 57,310 | +430.7% | 0.04% | +288.9% |
Q4 2021 | $1,584,000 | +64.1% | 10,799 | +98.0% | 0.01% | +80.0% |
Q3 2021 | $965,000 | -31.8% | 5,455 | -37.7% | 0.01% | -28.6% |
Q2 2021 | $1,415,000 | -41.3% | 8,762 | -37.8% | 0.01% | -46.2% |
Q1 2021 | $2,412,000 | +516.9% | 14,079 | +691.4% | 0.01% | +550.0% |
Q4 2020 | $391,000 | -70.9% | 1,779 | -78.0% | 0.00% | -77.8% |
Q3 2020 | $1,345,000 | -50.3% | 8,097 | -65.8% | 0.01% | -60.9% |
Q2 2020 | $2,707,000 | +326.3% | 23,707 | +186.9% | 0.02% | +283.3% |
Q1 2020 | $635,000 | +34.0% | 8,262 | +124.8% | 0.01% | +50.0% |
Q4 2019 | $474,000 | -82.2% | 3,676 | -85.8% | 0.00% | -77.8% |
Q2 2019 | $2,668,000 | +763.4% | 25,907 | +513.9% | 0.02% | +500.0% |
Q1 2019 | $309,000 | -66.4% | 4,220 | -80.6% | 0.00% | -62.5% |
Q4 2018 | $921,000 | +11.1% | 21,702 | -52.2% | 0.01% | 0.0% |
Q4 2017 | $829,000 | +737.4% | 45,430 | +151.7% | 0.01% | +700.0% |
Q2 2016 | $99,000 | -45.6% | 18,049 | +98.0% | 0.00% | 0.0% |
Q2 2014 | $182,000 | – | 9,116 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |